Cargando…
The T1799A point mutation is present in posterior uveal melanoma
An activating mutation in exon 15 of the BRAF gene is present in a high proportion of cutaneous pigmented lesions. Until recently this mutation had however only been identified in one case of posterior uveal melanoma. Despite this apparent lack of the BRAF mutation, inappropriate downstream activati...
Autores principales: | Janssen, C S, Sibbett, R, Henriquez, F L, McKay, I C, Kemp, E G, Roberts, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584949/ https://www.ncbi.nlm.nih.gov/pubmed/18985043 http://dx.doi.org/10.1038/sj.bjc.6604731 |
Ejemplares similares
-
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
por: Zuidervaart, W, et al.
Publicado: (2005) -
Episodic Src activation in uveal melanoma revealed by kinase activity profiling
por: Maat, W, et al.
Publicado: (2009) -
p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma
por: Awais, Raheela, et al.
Publicado: (2016) -
Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study
por: Thomas, S, et al.
Publicado: (2012) -
Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing
por: Kalirai, H, et al.
Publicado: (2014)